Alison M R, Poulsom R, Otto W R, Vig P, Brittan M, Direkze N C, Lovell M, Fang T C, Preston S L, Wright N A
Histopathology Unit, Cancer Research (UK), London WC2A 3PX, UK.
J Clin Pathol. 2004 Feb;57(2):113-20. doi: 10.1136/jcp.2003.010074.
A large body of evidence supports the idea that certain adult stem cells, particularly those of bone marrow origin, can engraft at alternative locations, particularly when the recipient organ is damaged. Under strong and positive selection pressure these cells will clonally expand/differentiate, making an important contribution to tissue replacement. Similarly, bone marrow derived cells can be amplified in vitro and differentiated into many types of tissue. Despite seemingly irrefutable evidence for stem cell plasticity, a veritable chorus of detractors has emerged, some doubting its very existence, motivated perhaps by more than a little self interest. The issues that have led to this situation include the inability to reproduce certain quite startling observations, and extrapolation from the behaviour of embryonic stem cells to suggest that adult bone marrow cells simply fuse with other cells and adopt their phenotype. Although these issues need resolving and, accepting that cell fusion does appear to allow reprogramming of haemopoietic cells in special circumstances, criticising this whole new field because some areas remain unclear is not good science.
大量证据支持这样一种观点,即某些成体干细胞,特别是骨髓来源的干细胞,能够在其他位置植入,尤其是当受体器官受损时。在强大的正向选择压力下,这些细胞会进行克隆性扩增/分化,对组织替代做出重要贡献。同样,骨髓来源的细胞可以在体外扩增并分化为多种类型的组织。尽管干细胞可塑性的证据看似无可辩驳,但还是出现了一群名副其实的 detractors,有些人怀疑其存在,这或许是出于一定的自身利益。导致这种情况的问题包括无法重现某些相当惊人的观察结果,以及从胚胎干细胞的行为进行推断,认为成体骨髓细胞只是与其他细胞融合并采用它们的表型。尽管这些问题需要解决,并且承认细胞融合在特殊情况下似乎确实能使造血细胞重编程,但因为某些领域仍不清楚就批评这个全新的领域,这不是科学的做法。